Free Trial
OTCMKTS:EVTCY

Evotec (EVTCY) Stock Price, News & Analysis

Evotec logo
$4.07 -0.10 (-2.40%)
As of 07/11/2025

About Evotec Stock (OTCMKTS:EVTCY)

Key Stats

Today's Range
$4.07
$4.14
50-Day Range
$3.76
$4.73
52-Week Range
$14.22
$26.57
Volume
29,351 shs
Average Volume
2,407 shs
Market Capitalization
$1.34 billion
P/E Ratio
9.93
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EVTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evotec and its competitors with MarketBeat's FREE daily newsletter.

EVTCY Stock News Headlines

Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
See More Headlines

EVTCY Stock Analysis - Frequently Asked Questions

Evotec's stock was trading at $4.16 at the beginning of the year. Since then, EVTCY shares have decreased by 2.2% and is now trading at $4.07.

Shares of Evotec split on the morning of Wednesday, October 20th 2021.The 3-1 split was announced on Wednesday, October 20th 2021. The newly minted shares were payable to shareholders after the closing bell on Wednesday, October 20th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Evotec subsidiaries include Central Glass Germany. GmbH, Central Glass Germany, Rigenerand Srl, GlaxoSmithKine's the Verona site, Just-Evotec Biologics, Aptuit, Cyprotex, and more.

Shares of EVTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EVTCY
CIK
1412558
Employees
4,200
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
$0.41
Trailing P/E Ratio
9.93
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.14 million
Net Margins
20.85%
Pretax Margin
23.90%
Return on Equity
16.02%
Return on Assets
7.81%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.57
Quick Ratio
2.50

Sales & Book Value

Annual Sales
$572.16 million
Price / Sales
2.35
Cash Flow
$0.04 per share
Price / Cash Flow
105.53
Book Value
$2.52 per share
Price / Book
1.62

Miscellaneous

Outstanding Shares
330,221,000
Free Float
N/A
Market Cap
$1.34 billion
Optionable
Not Optionable
Beta
0.98

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:EVTCY) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners